Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Barinthus Biotherapeutics Plc ADR (BRNS)

Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,817
  • Shares Outstanding, K 39,033
  • Annual Sales, $ 800 K
  • Annual Income, $ -73,350 K
  • 60-Month Beta -0.52
  • Price/Sales 68.14
  • Price/Cash Flow N/A
  • Price/Book 0.32
Trade BRNS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 2
  • High Estimate -0.38
  • Low Estimate -0.46
  • Prior Year -0.62
  • Growth Rate Est. (year over year) +32.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +18.48%
on 06/24/24
2.1400 -33.01%
on 06/06/24
-0.4764 (-24.94%)
since 05/31/24
3-Month
1.2100 +18.48%
on 06/24/24
4.1591 -65.53%
on 04/04/24
-0.9364 (-39.51%)
since 04/02/24
52-Week
1.2100 +18.48%
on 06/24/24
5.1000 -71.89%
on 11/06/23
-0.6264 (-30.41%)
since 06/30/23

Most Recent Stories

More News
Fed Speaks, Canada Inflation on Lineup Next Week

Monday U.S. Economic Lookahead Home builder confidence index (Feb.) Featured Earnings ...

AOT.TO : 0.51 (-8.93%)
FLOW.TO : 0.1900 (-13.64%)
SMT.TO : 0.85 (+11.84%)
DD : 79.36 (+0.11%)
CNM : 48.39 (-0.06%)
HQY : 85.76 (-0.99%)
HUMA : 5.11 (-4.84%)
BRNS : 1.4336 (+0.25%)

Business Summary

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus...

See More

Key Turning Points

3rd Resistance Point 1.4924
2nd Resistance Point 1.4712
1st Resistance Point 1.4524
Last Price 1.4336
1st Support Level 1.4124
2nd Support Level 1.3912
3rd Support Level 1.3724

See More

52-Week High 5.1000
Fibonacci 61.8% 3.6140
Fibonacci 50% 3.1550
Fibonacci 38.2% 2.6960
Last Price 1.4336
52-Week Low 1.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar